High levels of depression found among Canadian older adults with cancer during the COVID-19 pandemic

by University of TorontoCredit: Unsplash/CC0 Public DomainOlder adults who have had cancer had a high risk of experiencing symptoms of depression during the early months of the COVID-19 pandemic

Updated on: February 18,2024

High levels of depression found among Canadian older adults with cancer during the COVID-19 pandemic

by University of TorontoCredit: Unsplash/CC0 Public DomainOlder adults who have had cancer had a high risk of experiencing symptoms of depression during the early months of the COVID-19 pandemic

Updated on:February 18,2024

BMI's relation to cancer therapy mortality risks not so straightforward, study finds

byOsaka Metropolitan UniversityFor non-small cell lung cancer treatment, immunotherapy seems to pose less risk for persons under a certain BMI, while conventional chemotherapy appears optimal fo

Updated on: September 27,2024

BMI's relation to cancer therapy mortality risks not so straightforward, study finds

byOsaka Metropolitan UniversityFor non-small cell lung cancer treatment, immunotherapy seems to pose less risk for persons under a certain BMI, while conventional chemotherapy appears optimal fo

Updated on:September 27,2024

Survival similar for Black, White prostate cancer patients in clinical trial setting

by Elana GotkineFor metastatic castration-sensitive prostate cancer (mCSPC), overall survival and progression-free survival are similar for Black and White patients receiving first- or second-generati

Updated on: February 03,2024

Survival similar for Black, White prostate cancer patients in clinical trial setting

by Elana GotkineFor metastatic castration-sensitive prostate cancer (mCSPC), overall survival and progression-free survival are similar for Black and White patients receiving first- or second-generati

Updated on:February 03,2024

New report finds smoking rates, alcohol use, physical inactivity decreased during COVID-19

byAmerican Cancer SocietyNew ACS Report. Credit: American Cancer SocietyIn a new report, American Cancer Society (ACS) researchers discovered both favorable and unfavorable changes in major canc

Updated on: January 11,2024

New report finds smoking rates, alcohol use, physical inactivity decreased during COVID-19

byAmerican Cancer SocietyNew ACS Report. Credit: American Cancer SocietyIn a new report, American Cancer Society (ACS) researchers discovered both favorable and unfavorable changes in major canc

Updated on:January 11,2024

New thesis on prognostication for patients with myelodysplastic syndrome

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainMaria Creignou from the Hematology Unit (HERM) at the Department of Medicine, Huddinge (MedH) is defending her thesis: "Improving pro

Updated on: March 09,2024

New thesis on prognostication for patients with myelodysplastic syndrome

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainMaria Creignou from the Hematology Unit (HERM) at the Department of Medicine, Huddinge (MedH) is defending her thesis: "Improving pro

Updated on:March 09,2024

New method predicts the right treatment for breast cancer patients

byKarolinska InstitutetThe researchers developed and tested whole-tumor cell culture models derived from breast cancer patients that can predict how the tumors will respond to different treatmen

Updated on: January 13,2024

New method predicts the right treatment for breast cancer patients

byKarolinska InstitutetThe researchers developed and tested whole-tumor cell culture models derived from breast cancer patients that can predict how the tumors will respond to different treatmen

Updated on:January 13,2024

Review covers progress in immunotherapy for esophageal cancer

by Cactus CommunicationsMultiple ongoing clinical trials are being conducted to test the potential of ICIs as an adjuvant therapy for resectable esophageal cancer. The results of these trials could ce

Updated on: January 22,2024

Review covers progress in immunotherapy for esophageal cancer

by Cactus CommunicationsMultiple ongoing clinical trials are being conducted to test the potential of ICIs as an adjuvant therapy for resectable esophageal cancer. The results of these trials could ce

Updated on:January 22,2024

Researchers identify key metabolic regulators of drug resistance in the fight against pancreatic cancer

by Rebecca Brierley,University at BuffaloGraphical abstract. Credit:Molecular & Cellular Proteomics(2022). DOI: 10.1016/j.mcpro.2022.100409Researchers from the University at Buff

Updated on: February 20,2024

Researchers identify key metabolic regulators of drug resistance in the fight against pancreatic cancer

by Rebecca Brierley,University at BuffaloGraphical abstract. Credit:Molecular & Cellular Proteomics(2022). DOI: 10.1016/j.mcpro.2022.100409Researchers from the University at Buff

Updated on:February 20,2024

Shortage of vital children's cancer drug stirs fear and outrage

by Marie McCulloughCredit: CC0 Public DomainA critical shortage of a chemotherapy used to treat most childhood cancers has galvanized oncologists and parents of sick children.The U.S.medical com

Updated on: April 07,2024

Shortage of vital children's cancer drug stirs fear and outrage

by Marie McCulloughCredit: CC0 Public DomainA critical shortage of a chemotherapy used to treat most childhood cancers has galvanized oncologists and parents of sick children.The U.S.medical com

Updated on:April 07,2024

Ophthalmologic manifestations of acute leukemia are heterogeneous

by Elana GotkineOphthalmologic manifestations of acute leukemia are heterogeneous and detectable at initial presentation or relapse, according to a studypublishedonline July 10 in the&nbsp

Updated on: August 03,2024

Ophthalmologic manifestations of acute leukemia are heterogeneous

by Elana GotkineOphthalmologic manifestations of acute leukemia are heterogeneous and detectable at initial presentation or relapse, according to a studypublishedonline July 10 in the&nbsp

Updated on:August 03,2024

ASCO: Pembrolizumab superior for initial Tx of advanced NSCLC

(HealthDay)—For patients with programmed death ligand 1 (PD-L1)-expressing locally advanced or metastatic non-small-cell lung cancer (NSCLC), pembrolizumab is associated with better overall survival t

Updated on: March 30,2024

ASCO: Pembrolizumab superior for initial Tx of advanced NSCLC

(HealthDay)—For patients with programmed death ligand 1 (PD-L1)-expressing locally advanced or metastatic non-small-cell lung cancer (NSCLC), pembrolizumab is associated with better overall survival t

Updated on:March 30,2024

A new therapeutic strategy to improve treatment of aggressive endometrial cancer

by Autonomous University of BarcelonaERK5 inhibition impairs EC cell proliferation.AGenomic profiles of components of the MEK5-ERK5 pathway in EC patients obtained from Uterine Corpus

Updated on: February 23,2024

A new therapeutic strategy to improve treatment of aggressive endometrial cancer

by Autonomous University of BarcelonaERK5 inhibition impairs EC cell proliferation.AGenomic profiles of components of the MEK5-ERK5 pathway in EC patients obtained from Uterine Corpus

Updated on:February 23,2024